Trinity Biotech Correlations
| TRIB Stock | USD 0.77 0.02 2.53% |
The current 90-days correlation between Trinity Biotech plc and Beyond Air is 0.03 (i.e., Significant diversification). The correlation of Trinity Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Trinity Biotech Correlation With Market
Very good diversification
The correlation between Trinity Biotech plc and DJI is -0.34 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Trinity Biotech plc and DJI in the same portfolio, assuming nothing else is changed.
Moving against Trinity Stock
| 0.62 | IMDX | Insight Molecular Symbol Change | PairCorr |
| 0.55 | 4DX | 4DMEDICAL | PairCorr |
| 0.48 | AMS | Advanced Medical Sol | PairCorr |
| 0.47 | QIPT | Quipt Home Medical | PairCorr |
| 0.37 | AHG | Akso Health Group | PairCorr |
| 0.65 | TLT | Theralase Technologies | PairCorr |
| 0.52 | IMR | Imricor Medical Systems | PairCorr |
| 0.47 | AFME | Affluent Medical SAS | PairCorr |
| 0.43 | MODD | Modular Medical | PairCorr |
| 0.42 | EYE | Nova EYE Medical | PairCorr |
| 0.34 | CREO | Creo Medical Group | PairCorr |
| 0.31 | PRN | Profound Medical Corp | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Trinity Stock performing well and Trinity Biotech Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Trinity Biotech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ADVB | 4.00 | (0.76) | 0.00 | (0.55) | 0.00 | 8.11 | 28.22 | |||
| BGLC | 3.16 | (1.41) | 0.00 | (0.84) | 0.00 | 4.89 | 24.17 | |||
| XAIR | 7.35 | 0.27 | 0.04 | 0.54 | 6.15 | 14.46 | 163.02 | |||
| MRKR | 5.51 | 0.98 | 0.16 | 4.62 | 5.57 | 12.79 | 28.69 | |||
| CHEK | 9.87 | 2.66 | 0.41 | 0.71 | 6.07 | 17.16 | 198.26 | |||
| GBS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| SINT | 3.66 | (0.24) | 0.00 | (0.12) | 0.00 | 9.09 | 32.00 | |||
| EVGN | 2.70 | (0.32) | 0.00 | (0.25) | 0.00 | 4.20 | 24.36 | |||
| SNSE | 5.07 | 0.13 | 0.03 | 0.16 | 5.58 | 17.33 | 36.61 | |||
| TNON | 3.12 | (0.72) | 0.00 | (0.60) | 0.00 | 6.38 | 32.51 |
Trinity Biotech Corporate Management
| Simon Dunne | Chief Officer | Profile | |
| Fernando Devia | Ex Sales | Profile | |
| Eibhlin Kelly | Chief Officer | Profile | |
| Susan OConnor | Interim Officer | Profile | |
| Aris Kekedjian | CEO Chairman | Profile | |
| Louise Tallon | Chief Officer | Profile |